182 related articles for article (PubMed ID: 2118327)
1. Induction of the SOS response in Escherichia coli by azidothymidine and dideoxynucleosides.
Mamber SW; Brookshire KW; Forenza S
Antimicrob Agents Chemother; 1990 Jun; 34(6):1237-43. PubMed ID: 2118327
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
3. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.
Gao WY; Agbaria R; Driscoll JS; Mitsuya H
J Biol Chem; 1994 Apr; 269(17):12633-8. PubMed ID: 8175673
[TBL] [Abstract][Full Text] [Related]
4. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
Spector SA; Ripley D; Hsia K
Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-HIV 2'-beta-fluoro-2',3'-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production.
Tsai CH; Doong SL; Johns DG; Driscoll JS; Cheng YC
Biochem Pharmacol; 1994 Oct; 48(7):1477-81. PubMed ID: 7945448
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV activity of novel phosphonate derivatives of AZT, d4T, and ddA.
Pokrovsky AG; Pronayeva TR; Fedyuk NV; Shirokova EA; Khandazhinskaya AL; Tarusova NB; Karpenko IL; Krayevsky AA
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):767-9. PubMed ID: 11563112
[TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
[TBL] [Abstract][Full Text] [Related]
9. Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro.
Tsai CC; Follis KE; Benveniste RE
AIDS Res Hum Retroviruses; 1988 Oct; 4(5):359-68. PubMed ID: 2461724
[TBL] [Abstract][Full Text] [Related]
10. Bacterial DNA reactivity of the novel antitumor antibiotics PD 114,759 and PD 115,028 (veractamycins A and B).
Mamber SW; Okasinski WG; Pinter CD; Tunac JB
J Antibiot (Tokyo); 1987 Jul; 40(7):1044-9. PubMed ID: 3305453
[TBL] [Abstract][Full Text] [Related]
11. Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.
Schinazi RF; Sommadossi JP; Saalmann V; Cannon DL; Xie MY; Hart GC; Smith GA; Hahn EF
Antimicrob Agents Chemother; 1990 Jun; 34(6):1061-7. PubMed ID: 2393266
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the SOS response in Bacillus subtilis: evidence for a LexA repressor homolog.
Wojciechowski MF; Peterson KR; Love PE
J Bacteriol; 1991 Oct; 173(20):6489-98. PubMed ID: 1917874
[TBL] [Abstract][Full Text] [Related]
13. Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
Murakami K; Shirasaka T; Yoshioka H; Kojima E; Aoki S; Ford H; Driscoll JS; Kelley JA; Mitsuya H
J Med Chem; 1991 May; 34(5):1606-12. PubMed ID: 2033586
[TBL] [Abstract][Full Text] [Related]
14. Initial clinical experience with dideoxynucleosides as single agents and in combination therapy.
Yarchoan R; Pluda JM; Perno CF; Mitsuya H; Thomas RV; Wyvill KM; Broder S
Ann N Y Acad Sci; 1990; 616():328-43. PubMed ID: 2078027
[TBL] [Abstract][Full Text] [Related]
15. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells.
Cui L; Locatelli L; Xie MY; Sommadossi JP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1228-34. PubMed ID: 9067308
[TBL] [Abstract][Full Text] [Related]
16. 5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile.
Daluge SM; Purifoy DJ; Savina PM; St Clair MH; Parry NR; Dev IK; Novak P; Ayers KM; Reardon JE; Roberts GB
Antimicrob Agents Chemother; 1994 Jul; 38(7):1590-603. PubMed ID: 7526782
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of 2',3'-dideoxyinosine, 2',3'-dideoxyadenosine, 2',3'-dideoxyguanosine and 2',3'-dideoxycytidine by 500-MHz 1H-NMR spectroscopy and ab-initio molecular orbital calculations.
Plavec J; Koole LH; Chattopadhyaya J
J Biochem Biophys Methods; 1992 Dec; 25(4):253-72. PubMed ID: 1337354
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells.
Shirasaka T; Chokekijchai S; Yamada A; Gosselin G; Imbach JL; Mitsuya H
Antimicrob Agents Chemother; 1995 Nov; 39(11):2555-9. PubMed ID: 8585744
[TBL] [Abstract][Full Text] [Related]
19. Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages.
Thumann-Schweitzer C; Gosselin G; Périgaud C; Benzaria S; Girardet JL; Lefebvre I; Imbach JL; Kirn A; Aubertin AM
Res Virol; 1996; 147(2-3):155-63. PubMed ID: 8901435
[TBL] [Abstract][Full Text] [Related]
20. The DNA damage response of
Sass TH; Lovett ST
Proc Natl Acad Sci U S A; 2024 Jul; 121(27):e2407832121. PubMed ID: 38935560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
